Sangeeta Anand Gamre, the Founder & Director of Amethys Insights Pvt. Ltd., has forged a remarkable path in the pharmaceutical industry, bringing over 22 years of diverse experience, including three years in Health Economics and Outcomes Research (HEOR). She has consistently demonstrated the ability to drive operational excellence, foster innovation, and build sustainable business solutions that help organizations navigate the complexities of the pharmaceutical landscape. Sangeeta’s leadership and expertise have made her a sought-after consultant and mentor within the pharmaceutical and healthcare sectors.
“True innovation in healthcare comes from a place of collaboration and understanding that data-driven decisions pave the way for meaningful change.” – Sangeeta Anand Gamre
Amethys Insights Pvt. Ltd., founded in August 2024 and based in Mumbai, India, is an innovative consulting firm dedicated to enhancing the pharmaceutical sector’s focus on real-world evidence (RWE) and value-based healthcare. Under Sangeeta’s leadership, the company has established a strong foundation, offering a diverse range of technical services, including Health Economics and Outcomes Research (HEOR), Pharmacovigilance, Medical Writing, Intellectual Property Rights, and Market Access. By providing these cutting-edge solutions, Amethys Insights empowers pharmaceutical companies to bring value-based therapies to market and improve patient outcomes globally.
Sangeeta is widely known for her strategic mindset, pragmatic approach, and passion for data-driven decision-making. She blends her technical knowledge, leadership experience, and business development acumen to offer unparalleled insights into healthcare system challenges, all while maintaining a patient-centered approach. Her ability to steer multidisciplinary teams and ensure effective communication across all organizational levels has been critical in driving the company’s success.
Professional Journey & Industry Experience
Sangeeta’s journey into the pharmaceutical industry was not a conventional one. Her passion for healthcare, combined with a deep interest in data analytics, sparked her desire to explore the impact of healthcare decisions on patient outcomes and the healthcare system at large. Her career began in formulation development, where she gained in-depth knowledge of pharmaceutical sciences, including drug formulation, clinical trials, and the role of regulatory frameworks.
“Every step of my career has been about finding new ways to impact patient care and make the pharmaceutical industry more patient-centered. From formulation development to consulting, each phase has taught me the importance of data and collaboration in achieving positive health outcomes.” – Sangeeta Anand Gamre
Her first professional chapter, spent at Meyer Organics and Raptakos, Brett & Co. Ltd., provided Sangeeta with a broad understanding of R&D processes, regulatory compliance, and pharmaceutical marketing. These early roles laid the foundation for her future endeavors in HEOR and project management. However, it was her interest in the operational side of the pharmaceutical business that led her to explore the strategic role of project management in advancing healthcare solutions.
A major turning point in Sangeeta’s career came when she founded Amethys Insights Pvt. Ltd. Her ability to merge project management expertise with a strategic focus on evidence-based healthcare solutions opened up new avenues for the pharmaceutical industry to use data and research to improve patient care. The shift from purely technical roles into strategic business development and consulting enabled her to align industry objectives with broader societal goals, and this change shaped her leadership style and vision for the future of HEOR.
“Leadership is not just about making decisions—it’s about empowering others to make informed decisions that lead to the best possible outcomes. It’s about creating an environment where collaboration and innovation can thrive.” – Sangeeta Anand Gamre
Sangeeta’s consultancy focuses on the critical aspects of market access, regulatory compliance, and enhancing patient access to treatments. She is committed to helping pharmaceutical companies navigate the complexities of pricing and reimbursement, as well as ensuring the delivery of evidence-based solutions that align with both clinical and economic goals. Sangeeta’s leadership has been integral in Amethys Insights becoming a trusted partner for pharmaceutical companies looking to develop strategies that will lead to better health outcomes while controlling costs.
Key Leadership Attributes
“Innovation thrives when driven by collaboration and data-driven decision-making.”
As a leader, Sangeeta holds a deep belief that innovation stems from collaboration. Her leadership is rooted in the conviction that solutions to healthcare challenges can only be achieved when diverse perspectives are brought together to generate innovative ideas. She fosters a culture of teamwork and encourages cross-functional collaboration to ensure that all aspects of a project—from scientific research to regulatory affairs—are considered and incorporated into the final solution.
Sangeeta’s leadership philosophy is guided by three core principles:
- Empowering Teams: She believes in empowering her teams by encouraging continuous learning, development, and an open flow of communication. This approach helps her build well-rounded teams capable of solving complex healthcare problems. She provides a platform for individuals to contribute ideas and challenge conventional thinking, knowing that innovation is often born from diverse viewpoints.
- Data-Driven Decision Making: Sangeeta’s career has been defined by her focus on utilizing data to drive decisions. Whether it’s through leveraging big data analytics or employing real-world evidence (RWE), she ensures that all strategies and solutions are based on solid, empirical evidence. This data-driven approach not only helps to optimize patient outcomes but also ensures that cost-effectiveness remains at the heart of every project.
- Patient-Centered Focus: Sangeeta firmly believes that all healthcare solutions should prioritize patient well-being above all else. She encourages her team to always ask, “How will this benefit patients?” This focus on the patient has driven her to innovate in ways that go beyond clinical efficacy and towards improving overall patient quality of life.
“At the end of the day, it’s about people. It’s about making sure that patients can access the best treatments and live healthier, fuller lives. When we keep patients at the heart of everything we do, we not only drive innovation, we build a healthcare system that works for everyone.” – Sangeeta Anand Gamre
Vision for the Future of HEOR
Sangeeta’s vision for the future of Health Economics and Outcomes Research is deeply influenced by the increasing role of technology in healthcare. She envisions a future where data—particularly real-world evidence and artificial intelligence (AI)—drives decision-making in a way that makes healthcare more personalized and accessible.
“As technology evolves, so too must our approach to healthcare. Data, AI, and real-world evidence are not just tools—they are the future of how we can create better, more efficient healthcare systems that serve both patients and providers.” – Sangeeta Anand Gamre
As personalized medicine continues to evolve, Sangeeta sees tremendous potential for HEOR to play an even greater role in demonstrating the value of these therapies, not only from a clinical standpoint but also through economic analyses. With the ability to predict long-term outcomes using big data and machine learning, she anticipates that healthcare providers will be able to make decisions that benefit patients both in terms of clinical outcomes and cost-effectiveness.
“The future of HEOR lies in utilizing data to create value-based healthcare systems that ensure both clinical efficacy and cost-effectiveness.” – Sangeeta Anand Gamre
Sangeeta’s consultancy, Amethys Insights, is positioned to be at the forefront of this transformation. By offering tailored services and strategic guidance, Sangeeta and her team work closely with pharmaceutical companies to help them integrate cutting-edge technology and research into their business models. In this evolving landscape, Amethys Insights is committed to driving positive change, ensuring that healthcare companies remain agile, innovative, and patient-centric.
Impact and Legacy
Sangeeta’s professional legacy is built upon her belief that healthcare systems must evolve in ways that prioritize accessibility, affordability, and most importantly, patient care. She is passionate about creating a healthcare environment where patients receive the treatments they need, without the financial strain often associated with groundbreaking therapies.
“I want to leave behind a legacy that champions evidence-based decisions and improves patient care through collaborative innovation.” – Sangeeta Anand Gamre
Her work is focused not only on improving healthcare policies but also on creating systems that encourage collaboration between various stakeholders—from pharmaceutical companies to healthcare providers to policymakers. By empowering the next generation of healthcare leaders, Sangeeta hopes to create a ripple effect that will transform the way healthcare is delivered globally.
Industry Trends and Emerging Insights
Sangeeta is a thought leader who remains deeply engaged with emerging trends in the pharmaceutical and healthcare sectors. She identifies several key developments shaping the future of the industry:
- Real-World Evidence (RWE): RWE is one of the most significant trends in HEOR, as it provides insights into how treatments work in everyday clinical settings. By analyzing real-world data from patient registries, electronic health records, and other sources, RWE helps healthcare providers make better-informed decisions.
- Value-Based Healthcare Models: With rising healthcare costs, there is an increasing demand for models that focus on outcomes rather than volume. HEOR plays a critical role in evaluating the cost-effectiveness of therapies, ensuring that value-based pricing models can be implemented successfully.
- Advancements in Personalized Medicine: As biotechnology and genomics continue to advance, Sangeeta sees personalized medicine as an area with immense potential. HEOR can play a vital role in evaluating the economic value of personalized therapies and ensuring that they are accessible to the populations who need them most.
- Artificial Intelligence (AI) and Machine Learning: Sangeeta anticipates that AI and machine learning will revolutionize the way healthcare data is analyzed. These technologies will enable more accurate predictions, better resource allocation, and more targeted interventions, making them essential tools for the future of HEOR.
Personal Insights & Advice for Professionals
Sangeeta’s personal insights into the pharmaceutical industry reflect her passion for innovation, learning, and leadership. She encourages young professionals who are looking to build a career in HEOR to focus on developing both their technical and business skills. A deep understanding of the science behind drug development is crucial, but it is equally important to have a strong grasp of regulatory landscapes, market access strategies, and data analytics.
“To succeed in the pharmaceutical industry, one must blend scientific rigor with operational excellence.” – Sangeeta Anand Gamre
Her advice to young professionals is to remain adaptable and continuously seek out opportunities for learning. Whether through formal education, industry certifications, or mentorship, she believes that ongoing development is key to success in the ever-evolving pharmaceutical landscape.
Legacy & Future Vision
As Sangeeta continues to grow her business and contribute to the development of the pharmaceutical industry, her vision remains clear: to leave behind a legacy that prioritizes patient access to therapies, drives innovation in healthcare, and empowers the next generation of professionals to take the lead in transforming the industry.
“Every change, every innovation is an opportunity to make a difference. We are building a legacy of progress that will shape the future of healthcare for generations to come.” – Sangeeta Anand Gamre
Looking ahead, Sangeeta is committed to expanding the reach of Amethys Insights, influencing global healthcare policies, and ensuring that every pharmaceutical strategy is backed by solid evidence and aimed at improving patient outcomes. Through her work, Sangeeta hopes to create a more equitable healthcare system that benefits patients and society as a whole.